Ativos Alterar Data
3M USD 37.73B 122M 2025-12
Abbott USD 86.71B 2.53B 2025-12
AngioDynamics USD 269.68M 4.04M 2025-09
Anika Therapeutics USD 190.27M 833K 2025-12
AtriCure USD 654.18M 18.74M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Cooper Companies USD 12.42B 29.4M 2025-12
Dexcom USD 6.34B 1.16B 2025-12
Edwards Lifesciences USD 13.27B 216.5M 2025-09
Globus Medical USD 5.3B 207.12M 2025-12
Haemonetics USD 2.49B 48.73M 2025-12
Hologic USD 9.18B 165.8M 2025-12
ICU Medical USD 4.05B 52.39M 2025-12
Insulet USD 3.19B 161.1M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
J&J USD 199.21B 6.39B 2025-12
Medtronic USD 91.48B 139M 2025-12
Merit Medical Systems USD 2.69B 54.92M 2025-12
Olympus JPY 1.46T 73.12B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
STAAR Surgical USD 451.68M 4.68M 2025-12
Stryker USD 47.84B 787M 2025-12
Surmodics USD 169.82M 8.74M 2025-06
Tandem Diabetes Care USD 881.11M 6.46M 2025-12
Teleflex USD 6.95B 924.7M 2025-12
Terumo JPY 2.26T 362.12B 2025-12
Zimmer Biomet Holdings USD 23.09B 396.3M 2025-12